Asia-Pacific AI in healthcare market is estimated to grow significantly at a CAGR of 52.3% during the forecast period. The major countries which will contribute in the market include China, India and Japan. China is the biggest market for AI market. The artificial intelligence in Asia-Pacific region is largely driven by the investment from the private technology company towards artificial intelligence development owing to the availability of economical workforces coupled with large volume and broad range of data generated by the users of mobile internet and various applications.

The Asia-Pacific region has a potential market due to the increasing R&D and investments by big pharmaceutical companies in life science research coupled with harnessing innovation. In addition, increasing demand for integrated healthcare system and growing investment from healthcare IT companies as well as increasing geriatric population pool serve as the motivating factors for the growth of the market in the Asia-Pacific region.

The market is segmented on the basis of offering, end-user industry, and application. Based on offering, the market is divided into software & services and hardware. Based on the end-user industry, the market is segmented into hospitals & healthcare facilities, personal care, and biotechnology & pharmaceutical companies. Further, on the basis of application, the market is segmented into diagnosis, biomarker, virtual nursing assistance, remote monitoring of patients, drug discovery, and ai-enabled hospital care. On the basis of country, the market covers the analysis of China, India, Japan, and Rest of Asia-Pacific.

Japanese companies are planning tap medical market of India with funding and technological solutions, aiming at making healthcare more accessible. Japanese venture capital firms such as Spiral Ventures and India Japan Partnership Fund LLP are funding local health tech startups. In addition, these firms are exploring investment opportunities in healthcare industry.

Research Methodology

The market study of the Asia-Pacific AI in Healthcare market is incorporated by extensive primary and secondary research conducted by the research team.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for IT companies, private companies, healthcare companies, research institutes, hospitals, government organizations, and other market participants for the overall market and competitive analysis. The report provides an in-depth analysis on market size, and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Asia-Pacific AI in Healthcare Market Research and Analysis by Offering

2. Asia-Pacific AI in Healthcare Market Research and Analysis by End-User Industry

3. Asia-Pacific AI in Healthcare Market Research and Analysis by Application

The Report Covers

• Comprehensive research methodology of the Asia-Pacific AI in Healthcare market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Asia-Pacific AI in Healthcare market.
• Insights about market determinants which are stimulating the Asia-Pacific AI in Healthcare market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.